GOLDENWELL BIOTECH, INC. (GWLL)
Q3-CY2026Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014
Balance Sheet Date2026-Mar-312025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-30
Fiscal PeriodQ1-FY2026Q4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021Q4-FY2020Q3-FY2020
Total Revenue0$55$0$0$0$0$0$139$158$260$382$276$1,422$0$43,690$3,713$397$4,907$12,166$1,106$0$0$0$5$0$0$0$
QoQ%(100.00%).00%.00%.00%.00%.00%(100.00%)(12.03%)(39.23%)(31.94%)38.41%(80.59%).00%(100.00%)1,076.68%835.26%(91.91%)(59.67%)1,000.00%.00%.00%.00%(100.00%).00%.00%.00%
YoY%.00%.00%.00%(100.00%)(100.00%)(100.00%)(100.00%)(49.64%)(88.89%).00%(99.13%)(92.57%)258.19%(100.00%)259.12%235.71%.00%.00%.00%22,020.00%.00%.00%.00%
Cost Of Revenue0$43$0$0$0$0$0$69$0$187$196$138$711$0$20,663$1,763$188$2,329$5,775$525$0$0$0$0$0$0$0$
Gross Profit0$12$0$0$0$0$0$70$0$73$186$138$711$0$23,028$1,951$209$2,578$6,391$581$0$0$0$5$0$0$0$
Gross Margin21.82%53.80%50.36%.00%28.08%48.69%50.00%50.00%52.71%52.55%52.65%52.54%52.53%52.53%100.00%
Operating Expenses31,335$22,907$25,795$28,200$36,436$25,352$20,965$47,890$28,956$20,872$35,592$27,222$(34,317$)920,332$27,612$28,751$33,596$(150,479$)95,104$(24,429$)(46,851$)2,980$884$(146$)2,359$601$2,000$
Operating Income(31,335$)(22,895$)(25,795$)(28,200$)(36,436$)(25,352$)(20,965$)(47,820$)(28,956$)(20,799$)(35,406$)(27,084$)(33,606$)(920,332$)(4,584$)(26,800$)(33,387$)(100,253$)(88,713$)
Operating Margin(41,627.27%)14,769.62%(34,402.88%)(18,326.58%)(7,999.62%)(9,268.59%)(9,813.04%)(2,363.29%)(10.49%)(721.79%)(8,409.82%)(2,043.06%)(729.19%)
Interest Income5$12$
Interest Expenses2,100$2,100$2,100$2,100$2,100$2,100$2,100$2,100$2,100$0$0$0$0$0$0$0$
Income Before Tax(17,606$)(199,740$)(27,895$)(30,300$)(34,377$)(27,452$)(24,265$)(49,920$)(31,056$)(21,265$)(35,406$)(27,084$)(33,606$)(1,049,861$)4,584$(26,800$)(33,387$)(29,554$)(18,014$)(23,848$)(46,851$)(2,980$)(884$)(146$)(2,359$)(601$)(2,000$)
Tax Expenses0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
Net Income(17,606$)(199,740$)(27,895$)(30,300$)(38,536$)(27,452$)(24,265$)(49,920$)(30,977$)(21,265$)(35,406$)(27,084$)(33,606$)(1,049,861$)4,584$(26,800$)(33,380$)29,540$17,756$46,101$(46,101$)(2,975$)(879$)(141$)(2,329$)(323$)(1,988$)
Profit Margin(363,163.64%)17,427.85%(35,913.67%)(19,605.70%)(8,178.85%)(9,268.59%)(9,813.04%)(2,363.29%)10.49%(721.79%)(8,408.06%)602.00%145.95%4,168.26%(2,820.00%)
TTM(500,983.64%)(539,038.18%)32,502.53%29,445.57%(100,843.89%)(44,651.18%)(22,697.85%)(14,650.48%)(10,662.83%)(5,015.43%)(55,094.09%)(2,436.70%)(2,264.58%)(2,312.67%)(49.44%)(60.82%)323.09%260.17%111.37%(348.46%)(1,001,920.00%)(126,480.00%)(73,440.00%)(95,620.00%)
Earnings to Minority72,913$(1,200$)(99,840$)62,033$(466$)70,812$(129,529$)9,168$53,600$59,081$35,512$69,685$
Earnings to Common Shareholders(17,606$)(199,740$)(27,895$)(30,300$)(38,536$)(27,452$)(23,065$)(49,920$)(30,977$)(20,799$)(35,406$)(27,084$)(33,606$)(920,332$)(4,584$)(26,800$)(33,380$)(29,541$)(17,756$)(23,584$)(46,101$)(2,975$)(879$)(141$)(2,329$)(323$)(1,988$)
QoQ%91.19%(616.04%)7.94%21.37%(40.38%)(19.02%)53.80%(61.15%)(48.94%)41.26%(30.73%)19.41%96.35%(19,977.05%)82.90%19.71%(13.00%)(66.37%)24.71%48.84%(1,449.61%)(238.45%)(523.40%)93.95%(621.05%)83.75%
YoY%54.31%(627.60%)(20.94%)39.30%(24.40%)(31.99%)34.86%(84.32%)7.82%97.74%(672.38%)(1.06%)(.68%)(3,015.44%)74.18%(13.64%)27.59%(892.98%)(1,920.02%)(16,626.24%)(1,879.43%)(821.05%)55.79%
Earnings Per Share, Basic0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Earnings Per Share, Diluted0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Unlevered FCF Per Share, Basic0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Unlevered FCF Per Share, Diluted0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Average Shares, Basic96,433,33391,322,22291,322,22291,322,22291,322,22291,322,22280,000,00080,000,00080,000,00080,000,00028,121,781
Average Shares, Diluted99,000,00099,000,00096,433,33396,433,33399,000,00099,000,00096,433,33396,433,33399,000,00091,322,22291,322,22291,322,22291,322,22280,000,00080,000,00080,000,00080,000,00028,121,781
EBIT(15,506$)(197,640$)(25,795$)(28,200$)(32,277$)(25,352$)(22,165$)(47,820$)(28,956$)(21,265$)(35,406$)(27,084$)(33,606$)(1,049,861$)4,584$(26,800$)(33,387$)(29,554$)(18,014$)(23,848$)(46,851$)(2,980$)(884$)(146$)(2,359$)(601$)(2,000$)
EBITDA(15,506$)(197,640$)(25,795$)(28,200$)(32,277$)(25,352$)(22,165$)(47,820$)(28,956$)(21,265$)(35,406$)(27,084$)(33,606$)(1,049,861$)4,584$(26,800$)(33,387$)(29,554$)(18,014$)(23,848$)(46,851$)(2,980$)(884$)(146$)(2,359$)(601$)(2,000$)